Raymon Heather

SVP, Research and Development at ARTV

Sold, on record
$28k
Dollars the filings state
Form 4 sales
1
Latest May 19, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ARTVArtiva Biotherapeutics, Inc.SVP, Research and Development

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice ARTVNotice
    May 18, 2026 2026

    Filed to sell 3,500 shares ($32k)

    Raymon Heather, Officer, Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale ARTVNo plan
    May 19, 2026 +1 day

    Sold 3,095 shares at $9.01 ($28k)

    Raymon Heather, SVP, Research and Development

    No 10b5-1 planSold 2% of holdings ($1.4M position)148,228 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Raymon Heather
Source
May 19, 2026May 19, 2026ARTVSVP, Research and DevelopmentForm 4 sale3,095$28k2.0%No planSEC
May 18, 2026May 18, 2026ARTVOfficer, DirectorForm 144 notice3,500$32kNoticeSEC